Small drugs – Big considerations: How New Deal researchers are overcoming the challenges of scaling-up a potential IBD nanomedicine

A great chef could create an outstanding dish that revolutionizes [...]

From the lab to the market: regulations and development of new treatments.

Translating research ideas into prescription medicines is a long journey [...]

COVID-19 and Inflammatory Bowel Disease: an insight into the relationship between conditions

In December 2019 the now named severe acute respiratory syndrome [...]

August 26th, 2020|Inflammatory bowel diseases, Nanomedicine, Nanotherapy, New Deal|
Go to Top